ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
H02AB02 | G | Dexamethasone sodium phosphate - 8mg/2ml | 9289 | 2917/1 | RADOLINE | 8mg/2ml | 100x2ml | Injectable solution | IM/IV/Intraarticular/intralesional/soft tissue inj | Medi drug International SAL (MDI) | Pharmadex licensed by Orbucell pharma Canada | Lebanon | 2,612,610 L.L | 23.08 | B | 2/1/2023 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
H02AB02 | G | Dexamethasone - 8mg/2ml | 3885 | MP0050/95 | DEXAMED | 8mg/2ml | 100 x 2ml | Injectable solution | IV/IM | New Allpharma | Medochemie Ltd | Cyprus | 2,110,403 L.L | 23.08 | B | Medochemie Ltd | Cyprus | 2/1/2023 | 0 |
H02AB02 | G | Dexamethasone - 8mg/2ml | 8279 | 75515/1 | DEXAMED | 8mg/2ml | 10 x 2ml | Injectable solution | IV/IM | New Allpharma | Medochemie Ltd | Cyprus | 238,378 L.L | 23.08 | A1 | Medochemie Ltd | Cyprus | 2/1/2023 | 0 |
H02AB02 | G | Dexamethasone Phosphate - 8mg/2ml | 9694 | 29415/1 | DEXAMEDIS FORT | 8mg/2ml | 1x2ml | Injectable solution | IV/IM | Medis Pharm Drugstore | Les Laboratoires Medis SA | Tunisia | 30,270 L.L | 23.08 | A1 | 2/1/2023 | 0 | ||
H02AB02 | G | Dexamethasone Phosphate - 8mg/2ml | 10206 | 186418/1 | DEXASINA | 8mg/2ml | 100x2ml | Injectable solution | IV/IM | Ibn Sina Pharm SARL | Aburaihan Pharmaceutical Company | Iran | 2,443,376 L.L | 23.08 | B | Aburaihan Pharmaceutical Company | Iran | 2/1/2023 | 0 |